NASDAQ: ALLRAllarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?
Insider buying vs selling
Have Allarity Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ALLR insiders and whales buy or sell their stock.
ALLR Shareholders
What type of owners hold Allarity Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Leon Sass | 126.73% | 1,086,238 | $2.29M | Insider |
| Steen Knudsen | 14.58% | 124,976 | $263.70k | Insider |
| Renaissance Technologies LLC | 4.53% | 38,786 | $81.84k | Institution |
| Geode Capital Management LLC | 3.43% | 29,433 | $62.10k | Institution |
| Morgan Stanley | 3.35% | 28,713 | $60.58k | Institution |
| Duncan Moore | 2.65% | 22,672 | $47.84k | Insider |
| Bridgeway Capital Management LLC | 2.33% | 20,000 | $42.20k | Institution |
| Thomas Jensen | 2.08% | 17,841 | $37.64k | Insider |
| State Street Corp | 1.51% | 12,974 | $27.38k | Institution |
| Two Sigma Securities LLC | 1.46% | 12,534 | $26.45k | Institution |
ALLR vs Biotech Stocks
Allarity Therapeutics Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.